506235 announcements Alembic Ltd. announcements and dividends declared BSE
Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235
Alembic Ltd. 506235 listed on BSE and deals inAnnouncements and dividends declared by Alembic Ltd. 506235
Alembic Pharma gets USFDA nod for generic drug
Alembic Pharmaceuticals has been granted final approval from the USFDA for its generic Betamethasone Valerate Foam, intended to treat moderate-to-severe psoriasis of the scalp. This medication is equivalent to Luxiq Foam by Norvium Bioscience. Alembic’s
Announcement as on 26 August 2024
Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam.
Announcement as on 24 August 2024
Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam, 0.12%. The approved ANDA is therapeutically equivalent to the reference listed d
Announcement as on 24 August 2024
Alembic Pharma gets approval from US FDA to market generic medication
Alembic Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market a generic product indicated for prophylaxis of deep vein thrombosis. The company has received approval from the US Food and Drug Administration (USFDA)
Announcement as on 13 August 2024
Alembic gets USFDA nod for generic medication
Alembic Pharmaceuticals announced approval from the USFDA to market Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis prophylaxis, equivalent to Pradaxa Capsules. The company now has 211 ANDA approvals. Shares closed 3.17% lower at Rs 1,076 o
Announcement as on 13 August 2024
Announcements by Alembic Ltd. first page | Next page | Prev page |
506235 Alembic Ltd. current price & indicator signals
Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 24 Mon Aug 2026 | 91.61 | 91.19 to 93.93 | -1.21% | 0.61 times |
| 21 Fri Aug 2026 | 92.73 | 90.60 to 93.19 | 1.42% | 1.21 times |
| 20 Thu Aug 2026 | 91.43 | 87.25 to 92.50 | 3.05% | 1.61 times |
| 19 Wed Aug 2026 | 88.72 | 87.98 to 90.03 | -1.08% | 0.62 times |
| 18 Tue Aug 2026 | 89.69 | 88.00 to 90.55 | -0.4% | 1.09 times |
| 17 Mon Aug 2026 | 90.05 | 85.81 to 90.50 | 3.83% | 1.55 times |
| 14 Fri Aug 2026 | 86.73 | 82.75 to 87.64 | 3.57% | 2.66 times |
| 13 Thu Aug 2026 | 83.74 | 83.39 to 84.88 | -1.4% | 0.21 times |
| 12 Wed Aug 2026 | 84.93 | 83.56 to 86.70 | -2.11% | 0.4 times |
| 11 Tue Aug 2026 | 86.76 | 85.00 to 86.86 | 2.43% | 0.37 times |
| 10 Mon Aug 2026 | 84.70 | 84.00 to 85.98 | -0.08% | 0.28 times |
| 07 Fri Aug 2026 | 84.77 | 84.50 to 87.45 | -2.27% | 0.55 times |
Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


